These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

699 related items for PubMed ID: 19249511

  • 21. Effect of calcineurin inhibitors on low-density lipoprotein oxidation.
    Cofan F, Cofan M, Campos B, Guerra R, Campistol JM, Oppenheimer F.
    Transplant Proc; 2005 Nov; 37(9):3791-3. PubMed ID: 16386540
    [Abstract] [Full Text] [Related]

  • 22. Effects of cyclosporine-tacrolimus switching in posttransplantation hyperlipidemia on high-density lipoprotein 2/3, lipoprotein a1/b, and other lipid parameters.
    Seymen P, Yildiz M, Türkmen MF, Titiz MI, Seymen HO.
    Transplant Proc; 2009 Dec; 41(10):4181-3. PubMed ID: 20005364
    [Abstract] [Full Text] [Related]

  • 23. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.
    White M, Haddad H, Leblanc MH, Giannetti N, Pflugfelder P, Davies R, Isaac D, Burton J, Chan M, Azevedo E, Howlett J, Ignaszewski A, Busque S, Cantarovich M, Ferguson R, Genest J, Ross H.
    J Heart Lung Transplant; 2005 Jul; 24(7):798-809. PubMed ID: 15982605
    [Abstract] [Full Text] [Related]

  • 24. Hyperuricaemia in cyclosporin-treated patients: GFR-related effect.
    Zürcher RM, Bock HA, Thiel G.
    Nephrol Dial Transplant; 1996 Jan; 11(1):153-8. PubMed ID: 8649625
    [Abstract] [Full Text] [Related]

  • 25. Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus.
    White M, Ross H, Haddad H, LeBlanc MH, Racine N, Pflugfelder P, Giannetti N, Davies R, Azevedo E, Isaac D, Burton J, Ferguson R, Genest J.
    Transplantation; 2006 Sep 27; 82(6):763-70. PubMed ID: 17006323
    [Abstract] [Full Text] [Related]

  • 26. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
    Opelz G, Döhler B, Collaborative Transplant Study.
    Transplantation; 2009 Mar 27; 87(6):795-802. PubMed ID: 19300179
    [Abstract] [Full Text] [Related]

  • 27. Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
    Bolin P, Shihab FS, Mulloy L, Henning AK, Gao J, Bartucci M, Holman J, First MR, OPTIMA Study Group.
    Transplantation; 2008 Jul 15; 86(1):88-95. PubMed ID: 18622283
    [Abstract] [Full Text] [Related]

  • 28. A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients.
    Kim SJ, Prasad GV, Huang M, Nash MM, Famure O, Park J, Thenganatt MA, Chowdhury N, Cole EH, Fenton SS, Cattran DC, Zaltzman JS, Cardella CJ.
    Transplantation; 2006 Oct 15; 82(7):924-30. PubMed ID: 17038908
    [Abstract] [Full Text] [Related]

  • 29. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
    El-Agroudy AE, El-Dahshan K, Mahmoud K, Ismail AM, El-Baz M, Shokeir AA, Ghoneim MA.
    Exp Clin Transplant; 2008 Sep 15; 6(3):203-10. PubMed ID: 18954298
    [Abstract] [Full Text] [Related]

  • 30. Kidney graft function in long-term cyclosporine and tacrolimus treatment: comparative study with nephrotoxicity markers.
    Marchewka Z, Kuźniar J, Zynek-Litwin M, Falkiewicz K, Szymańska B, Roszkowska A, Klinger M.
    Transplant Proc; 2009 Jun 15; 41(5):1660-5. PubMed ID: 19545703
    [Abstract] [Full Text] [Related]

  • 31. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
    Tumgor G, Arikan C, Kilic M, Aydogdu S.
    Pediatr Transplant; 2006 Sep 15; 10(6):665-8. PubMed ID: 16911488
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Influence of cyclosporine A and FK506 on 24 h blood pressure monitoring in kidney transplant recipients.
    Hohage H, Brückner D, Arlt M, Buchholz B, Zidek W, Spieker C.
    Clin Nephrol; 1996 May 15; 45(5):342-4. PubMed ID: 8738668
    [Abstract] [Full Text] [Related]

  • 34. Stable graft function after reduction of calcineurin inhibitor dosage in paediatric kidney transplant patients.
    Plank C, Benz K, Amann K, Nüsken KD, Dittrich K, Rascher W, Sauerstein K, Stuppy A, Klare B, Dötsch J.
    Nephrol Dial Transplant; 2006 Oct 15; 21(10):2930-7. PubMed ID: 16837512
    [Abstract] [Full Text] [Related]

  • 35. Do blood pressure and arterial wall properties change after conversion from cyclosporine to tacrolimus?
    Gelens MA, Christiaans MH, v Hooff JP.
    Transplant Proc; 2005 May 15; 37(4):1900-1. PubMed ID: 15919498
    [Abstract] [Full Text] [Related]

  • 36. Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations.
    Tory R, Sachs-Barrable K, Goshko CB, Hill JS, Wasan KM.
    Transplantation; 2009 Jul 15; 88(1):62-8. PubMed ID: 19584682
    [Abstract] [Full Text] [Related]

  • 37. Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial.
    Meier M, Nitschke M, Weidtmann B, Jabs WJ, Wong W, Suefke S, Steinhoff J, Fricke L.
    Transplantation; 2006 Apr 15; 81(7):1035-40. PubMed ID: 16612281
    [Abstract] [Full Text] [Related]

  • 38. Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors.
    Meçule A, Poli L, Nofroni I, Bachetoni A, Tinti F, Umbro I, Barile M, Berloco PB, Mitterhofer AP.
    Transplant Proc; 2010 May 15; 42(4):1317-9. PubMed ID: 20534290
    [Abstract] [Full Text] [Related]

  • 39. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B, Kubanek M, Malek I, Vymetalova Y, Hoskova L, Podzimkova M, Kautzner J.
    J Heart Lung Transplant; 2009 Jun 15; 28(6):598-604. PubMed ID: 19481021
    [Abstract] [Full Text] [Related]

  • 40. Renal function in patients with cadaveric kidney transplants treated with tacrolimus or cyclosporine.
    Gonzalez Molina M, Morales JM, Marcen R, Campistol JM, Oppenheimer F, Serón D, Gil-Vernet S, Capdevila L, Andrés A, Lampreave I, Del Castillo D, Cabello M, Burgos D, Valdés F, Anaya F, Escuín F, Arias M, Pallardó L, Bustamante J.
    Transplant Proc; 2007 Sep 15; 39(7):2167-9. PubMed ID: 17889126
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.